Randomized, Open‐Label, Single‐Dose, Parallel‐Group Pharmacokinetic Study of PF‐06410293 (adalimumab‐afzb), an Adalimumab Biosimilar, by Subcutaneous Dosing Using a Prefilled Syrin...

por Cox, Donna S., Alvarez, Daniel F., Bock, Amy E., Cronenberger, Carol L.
Publicado 2021

Ponezumab in mild-to-moderate Alzheimer's disease: Randomized phase II PET-PIB study

por Landen, Jaren W., Andreasen, Niels, Cronenberger, Carol L., Schwartz, Pamela F., Börjesson-Hanson, Anne, Östlund, Henrik, Sattler, Catherine A., Binneman, Brendon, Bednar, Martin M.
Publicado 2017